Reproductive Medicine Associates of New Jersey
56
6
6
39
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
8 terminated/withdrawn out of 56 trials
83.0%
-3.5% vs industry average
2%
1 trials in Phase 3/4
0%
0 of 39 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (56)
The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
Role: lead
Male Infertility and Assisted Reproductive Technologies Research Biobank
Role: lead
Quantifying Uterine Elastography in Menstruating Women
Role: lead
FirmTech User Research Trial
Role: lead
PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer
Role: lead
Uterine Elastography: a Potential Predictor of Embryo Transfer Success
Role: lead
Platelet Rich Plasma for Insufficient Endometrium
Role: lead
Investigating Micro-Manipulation Procedures for Assisted Hatching Timing
Role: lead
Evaluation of Donated Human Embryos Following in Vitro Fertilization
Role: lead
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
Role: lead
Discarded Materials Study
Role: lead
Study of Gene Associations and Infertility
Role: lead
Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response
Role: lead
Embryonic Ploidy Status in the Oncofertility Population
Role: lead
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
Role: lead
The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting
Role: lead
Transcriptomic Evaluation of Endometrial Receptivity
Role: lead
The Human Microbiome and IVF Outcomes
Role: lead
Evaluation of Discarded Laboratory Pathological Specimens and Media
Role: lead
Fresh Vs Frozen Surgical Sperm in IVF
Role: lead